BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12204562)

  • 1. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability.
    Paolino D; Ventura CA; Nisticò S; Puglisi G; Fresta M
    Int J Pharm; 2002 Sep; 244(1-2):21-31. PubMed ID: 12204562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
    Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
    Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal delivery of ketoprofen using microemulsions.
    Rhee YS; Choi JG; Park ES; Chi SC
    Int J Pharm; 2001 Oct; 228(1-2):161-70. PubMed ID: 11576778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug.
    Valenta C; Wanka M; Heidlas J
    J Control Release; 2000 Jan; 63(1-2):165-73. PubMed ID: 10640590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoprofen Microemulsion for Improved Skin Delivery and In Vivo Anti-inflammatory Effect.
    Aliberti ALM; de Queiroz AC; Praça FSG; Eloy JO; Bentley MVLB; Medina WSG
    AAPS PharmSciTech; 2017 Oct; 18(7):2783-2791. PubMed ID: 28374340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microemulsion-Based Topical Hydrogels of Tenoxicam for Treatment of Arthritis.
    Goindi S; Narula M; Kalra A
    AAPS PharmSciTech; 2016 Jun; 17(3):597-606. PubMed ID: 26285672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery.
    Ustündağ Okur N; Yavaşoğlu A; Karasulu HY
    Chem Pharm Bull (Tokyo); 2014; 62(2):135-43. PubMed ID: 24492583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
    Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
    Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects.
    Takeshi M; Ebihara T; Maekawa K; Yamamoto K; Higo N
    Int J Pharm; 2014 Apr; 465(1-2):197-201. PubMed ID: 24530385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine.
    Zhang J; Michniak-Kohn B
    Int J Pharm; 2011 Dec; 421(1):34-44. PubMed ID: 21959104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of microemulsions containing orange oil with water and propylene glycol as hydrophilic components.
    Yotsawimonwat S; Okonoki S; Krauel K; Sirithunyalug J; Sirithunyalug B; Rades T
    Pharmazie; 2006 Nov; 61(11):920-6. PubMed ID: 17152984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoprofen-loaded polymer carriers in bigel formulation: an approach to enhancing drug photostability in topical application forms.
    Andonova V; Peneva P; Georgiev GS; Toncheva VT; Apostolova E; Peychev Z; Dimitrova S; Katsarova M; Petrova N; Kassarova M
    Int J Nanomedicine; 2017; 12():6221-6238. PubMed ID: 28894363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions.
    Garcia MT; da Silva CH; de Oliveira DC; Braga EC; Thomazini JA; Bentley MV
    Pharm Res; 2006 Aug; 23(8):1776-85. PubMed ID: 16858649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative bioavailability of ketoprofen 20% in a poloxamer-lecithin organogel.
    Dowling TC; Arjomand M; Lin ET; Allen LV; McPherson ML
    Am J Health Syst Pharm; 2004 Dec; 61(23):2541-4. PubMed ID: 15595229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the skin permeation of clindamycin phosphate by Aerosol OT/1-butanol microemulsions.
    Junyaprasert VB; Boonsaner P; Leatwimonlak S; Boonme P
    Drug Dev Ind Pharm; 2007 Aug; 33(8):874-80. PubMed ID: 17729105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
    Kantarci G; Ozgüney I; Karasulu HY; Arzik S; Güneri T
    AAPS PharmSciTech; 2007 Nov; 8(4):E91. PubMed ID: 18181551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.